BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34210216)

  • 1. Omniflow II biosynthetic grafts versus expanded polytetrafluoroethylene grafts for infrainguinal bypass surgery. A single-center retrospective analysis.
    van de Laar BC; van Heusden HC; Pasker-de Jong PC; van Weel V
    Vascular; 2022 Aug; 30(4):749-758. PubMed ID: 34210216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omniflow® II biosynthetic graft offers acceptable early and mid-term outcomes in redo surgery in patients with critical limb-threatening ischemia with no available autologous vein material.
    Troisi N; Socrate AM; Vigliotti G; Dorrucci V; Benedetto F; Frigatti P; Michelagnoli S; Berchiolli R;
    Int Angiol; 2024 Apr; 43(2):255-261. PubMed ID: 38345547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid- and long-term results of the treatment of infrainguinal arterial occlusive disease with precuffed expanded polytetrafluoroethylene grafts compared with vein grafts.
    Loh SA; Howell BS; Rockman CB; Cayne NS; Adelman MA; Gulkarov I; Veith FJ; Maldonado TS
    Ann Vasc Surg; 2013 Feb; 27(2):208-17. PubMed ID: 22998787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.
    Donker JM; Ho GH; Te Slaa A; de Groot HG; van der Waal JC; Veen EJ; van der Laan L
    Vasc Endovascular Surg; 2011 Oct; 45(7):598-603. PubMed ID: 21757494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure.
    Brumberg RS; Back MR; Armstrong PA; Cuthbertson D; Shames ML; Johnson BL; Bandyk DF
    J Vasc Surg; 2007 Dec; 46(6):1160-6. PubMed ID: 17920227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics.
    Dorigo W; Pulli R; Castelli P; Dorrucci V; Ferilli F; De Blasis G; Monaca V; Vecchiati E; Pratesi C;
    J Vasc Surg; 2011 Nov; 54(5):1332-8. PubMed ID: 21840151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results.
    Bosiers M; Deloose K; Verbist J; Schroë H; Lauwers G; Lansink W; Peeters P
    J Vasc Surg; 2006 Feb; 43(2):313-8; discussion 318-9. PubMed ID: 16476607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midterm Results of a Japanese Prospective Multicenter Registry of Heparin-Bonded Expanded Polytetrafluoroethylene Grafts for Above-the-Knee Femoropopliteal Bypass.
    Shibutani S; Obara H; Matsubara K; Toya N; Isogai N; Ogino H; Watada S; Asami A; Kudo T; Kanaoka Y; Fujimura N; Harada H; Uchiyama H; Sato Y; Ohki T;
    Circ J; 2020 Feb; 84(3):501-508. PubMed ID: 32062636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
    Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
    J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results.
    Walluscheck KP; Bierkandt S; Brandt M; Cremer J
    J Cardiovasc Surg (Torino); 2005 Aug; 46(4):425-30. PubMed ID: 16160689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of PTFE trilaminate graft versus venous graft and composite graft for below-the-knee revascularization.
    Mazzaccaro D; De Febis E; Settembrini AM; Tassinari L; Carmo M; Settembrini PG
    J Cardiovasc Surg (Torino); 2014 Oct; 55(5):685-91. PubMed ID: 25008059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.
    Suckow BD; Kraiss LW; Stone DH; Schanzer A; Bertges DJ; Baril DT; Cronenwett JL; Goodney PP;
    Ann Vasc Surg; 2013 Nov; 27(8):1134-45. PubMed ID: 24011814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft.
    Pulli R; Dorigo W; Castelli P; Dorrucci V; Ferilli F; De Blasis G; Monaca V; Vecchiati E; Pratesi C;
    J Vasc Surg; 2010 May; 51(5):1167-1177.e1. PubMed ID: 20347549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery.
    van der Slegt J; Steunenberg SL; Donker JM; Veen EJ; Ho GH; de Groot HG; van der Laan L
    J Vasc Surg; 2014 Jul; 60(1):120-8. PubMed ID: 24629990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access.
    Arhuidese I; Reifsnyder T; Islam T; Karim O; Nejim B; Obeid T; Qazi U; Malas M
    J Vasc Surg; 2017 Mar; 65(3):775-782. PubMed ID: 28236920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts.
    Sala F; Hassen-Khodja R; Lecis A; Bouillanne PJ; Declemy S; Batt M
    Ann Vasc Surg; 2003 Jul; 17(4):401-7. PubMed ID: 14670018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.